November 2005
The results of the HypoMon® children pre-clinical studies were presented at the 5th Annual Diabetes Technology Meeting, San Francisco 2005.

September 2005
Frontline Systems (Frontline) provides Sun Microsystems™ multi-processor workstations for computational algorithm development.

June 2005
The results of the HypoMon® adult pre-clinical studies were presented at the 65th Annual American Diabetes Association (ADA) Conference, San Diego 2005.

March 2005
AiMedics commences clinical studies of the HypoMon® for Type1 diabetic children at the Princess Margaret Hospital for children (PMH) in Perth.

February 2005 -
AiMedics is formally granted the HypoMon® New Zealand patent. Pat No. 527818.

September 2004 -
AiMedics is formally granted the HypoMon® Australian patent. Pat No. 2002233052.

Results to date of the HypoMon® clinical trials were presented to the Australian Diabetes Society (ADS) in Sydney.

July 2004 -
The ABC News and Current Affairs featured a news article of the HypoMon®, on the 7-o'clock news. Click here for further information.

June 2004 -
HypoMon® preliminary results were presented at the 64th Annual American Diabetes Association (ADA) Conference, Orlando 2004.

May 2004 -
AiMedics commences phase I clinical studies of the HypoMon® at the Prince of Wales Hospital, Sydney.

March 2004 -
AiMedics' international PCT patent application for the HypoMon® technology is granted by the Australian and New Zealand patent offices.

November 2003 -
The HypoMon® 'proof-of-concept' prototype units completed for pre-clinical studies. Click here to view these prototypes. A preview of HypoMon® second generation prototypes can be viewed here.

May 2003 -
The HypoMon® prototype was featured in an Australian national daily newspaper 'The Australian', titled 'Alarm life-saver for diabetics'. For further information, click here.

February 2003 -
AiMedics has formed a strategic alliance with an international scientific collaboration partner, for the development of the HypoMon® device. Healthcare Technology Limited (HTL), is a UK-based privately-owned, high technology manufacturing and distribution company, with branch offices in USA, France, Denmark, Australia and Taiwan. HTL owns CardioSport® brand of heart rate monitors and licences its technology to Reebok®.

September 2002 -
The miniaturised HypoMon device is featured in UTS's newspaper, titled 'UTS backs pioneering diabetes monitor'. For further information, click here.The early version of the HypoMon® device was featured in a cover story of the University of Technology, Sydney's (UTS) bi-monthly newspaper, titled 'HypoMon sweetens diabetic lives'. For further information, click here.

May 2002 -
Professor Hung Nguyen was appointed a Member in the General Division of the Order of Australia (AM) for his service to engineering through biomedical technology research and education.

January 2002 -
Recipient of the NSW government's Department of State and Regional Development BioFirst grant for the development of the HypoMon® device system.

December 2001 -
Recipient of the prestigious Commonwealth government's Biotechnology Innovation Fund (BIF) grant. In addition, AiMedics has also received NSW government's biotechnology grant in January 2002.

page: Previous

Webmaster: admin@aimedics.com
© AiMedics 2009 | Disclaimer